logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12295967 B1

PDFFull Text
Date of Patent:
May. 13, 2025

Filed:

Apr. 24, 2019

Pharmaceutical composition for prevention or treatment of flavivirus infection

Applicants:

Lemonex Inc., Seoul, KR;

Seoul National University R&db Foundation, Seoul, KR;

Inventors:

Cheol Hee Won, Seoul, KR;

Dal Hee Min, Seoul, KR;

Assignees:

LEMONEX INC., Seoul, KR;

SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION, Seoul, KR;

Attorney:

The PL Law Group, PLLC

Primary Examiner:

Eric Olson

Assistant Examiner:

Benjamin M Brandsen

Int. Cl.
CPC ...
A61K 31/7036 (2006.01); A61K 31/282 (2006.01); A61K 31/47 (2006.01); A61K 31/4706 (2006.01); A61K 31/496 (2006.01); A61K 31/536 (2006.01); A61K 31/5415 (2006.01); A61K 31/546 (2006.01); A61K 31/661 (2006.01); A61K 31/7048 (2006.01); A61K 38/12 (2006.01); A61K 38/14 (2006.01); A61P 31/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7036 (2013.01); A61K 31/282 (2013.01); A61K 31/47 (2013.01); A61K 31/4706 (2013.01); A61K 31/496 (2013.01); A61K 31/536 (2013.01); A61K 31/5415 (2013.01); A61K 31/546 (2013.01); A61K 31/661 (2013.01); A61K 31/7048 (2013.01); A61K 38/12 (2013.01); A61K 38/14 (2013.01); A61P 31/14 (2018.01); C12Y 203/01059 (2013.01);
Abstract

A method for treating a flavivirus infection includes administering to a subject in need thereof a composition which includes at least one of gentamicin sulfate, netilmicin, tobramycin, paromomycin, amikacin, capreomycin, trifluoperazine, dihydrostreptomycin, hydroxychloroquine, thioridazine HCl, efavirenz, miltefosine, nystatin, micafungin, bleomycin, resminostat, montelukast, norfloxacin, nedaplatin and cephalothin, which can exhibit excellent growth inhibition or killing effects of various species of flavivirus genus.

Find Patent Forward Citations

Won, Cheol. (2025). Pharmaceutical composition for prevention or treatment of flavivirus infection (U.S. Patent No. 12295967). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12295967

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…